Targeted protein degradation promises to lead the way to effective drugs for challenging targets

Researchers are using targeted protein degradation as a strategy to develop drugs that target disease-causing proteins where traditional inhibitor drugs can’t be used. 

In this infographic, we discuss both inhibition and degradation, the advantages and challenges related to each approach, and the key points you need to consider when designing your protein degraders. 

 

Learn how researchers are using NanoTemper tools to evaluate the affinity and specificity of their PROTAC candidate. 

Previous Article
How stability studies get your mAb candidate FDA-approved
How stability studies get your mAb candidate FDA-approved

Up next
4 ways to help you overcome the limitations of current methods in neurodegenerative disease research
4 ways to help you overcome the limitations of current methods in neurodegenerative disease research